Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 18, 2024 |
8-k | 8K-related | 16 | Dec 17, 2024 |
4 | Insider transactions | 1 | Dec 06, 2024 |
8-k | 8K-related | 14 | Dec 03, 2024 |
3 | Insider transactions | 2 | Dec 02, 2024 |
8-k/a | 8K-related | 14 | Nov 27, 2024 |
8-k/a | 8K-related | 14 | Nov 26, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
3 | Insider transactions | 2 | Nov 22, 2024 |